The Medtronic Newsroom is designed to assist media in finding news and information about our company.
Medtronic, founded in a Minneapolis garage in 1949 by Earl Bakken and his brother-in-law, Palmer Hermundslie, is the world’s leading maker of medical devices.
Our Mission has not changed since Earl Bakken wrote it in 1960: To contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health and extend life.
More than 9 million lives are enhanced every year by a Medtronic product or therapy; that’s one every three seconds.
Medtronic is headquartered in Minneapolis, MN and operates in more than 140 countries. The company employs 49,000 people, including 5,800 scientists and engineers, pursuing research and innovation that has led to more than 28,000 patents.
|12/19/14||Medtronic Completes Global User Evaluations for New Insulin Pump Platform|
|Next-Generation System with Breakthrough Advancement in Closed-Loop Technology Furthers Global Innovation MINNEAPOLIS - December 19, 2014 - Medtronic, Inc. (NYSE:MDT) today announced it has completed global user evaluations of a next generation system that uses the new pump platform and represents a key step toward development of an artificial pancreas. The completely redesigned insulin delivery system comes with new features that offer convenience in managing diabetes and improved design eleme... |
|12/16/14||Three Colorado Agencies Receive Medtronic Health Access Grant|
|Medtronic Philanthropy Grants Support Local Organizations Committed to Expanding Access to Healthcare for the Underserved MINNEAPOLIS - December 16, 2014 - Rocky Mountain Youth Clinics, Roundup River Ranch and the Parkinson Association of the Rockies each received a two-year $50,000 Health Access Grant from Medtronic Philanthropy in recognition of their continued commitment to improve access to healthcare. Each was nominated by a team of Medtronic employees working in Louisville, CO. Rocky M... |
|12/15/14||Medtronic Launches NovaShield(TM) Injectable Nasal Packing and Stent for Functional Endoscopic Sinus Surgery (FESS) |
|NovaShield(TM) Offers Convenient Tool to Control Minimal Bleeding, Prevent Adhesions, and Provide Antibacterial Effectiveness after FESS* MINNEAPOLIS - December 15, 2014 - Medtronic (NYSE: MDT) today announced the launch of the NovaShield(TM) Injectable Nasal Packing and Stent for functional endoscopic sinus surgery (FESS), manufactured by the company's Ear Nose and Throat (ENT) division of its Surgical Technologies business. Made from chitosan, NovaShield is a ready-to-use gel placed in the s... |
|Receive E-mail Alerts |
|Sign up to receive e-mail alerts whenever Medtronic posts new information to the site. Just enter your e-mail address and click Submit.|